$-0.28 EPS Expected for Soleno Therapeutics, Inc. (SLNO); EQUITABLE GROUP ORDINARY SHARES CAN (EQGPF) Shorts Increased By 1.96%

Equitable Group Inc. (OTCMKTS:EQGPF) Logo

Analysts expect Soleno Therapeutics, Inc. (NASDAQ:SLNO) to report $-0.28 EPS on April, 1.They anticipate $0.11 EPS change or 28.21% from last quarter’s $-0.39 EPS. After having $-0.11 EPS previously, Soleno Therapeutics, Inc.’s analysts see 154.55% EPS growth. The stock decreased 3.57% or $0.05 during the last trading session, reaching $1.35. About 460,292 shares traded or 647.23% up from the average. Soleno Therapeutics, Inc. (NASDAQ:SLNO) has declined 12.28% since March 15, 2018 and is downtrending. It has underperformed by 16.65% the S&P500. Some Historical SLNO News: 14/05/2018 – Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome; 14/05/2018 Soleno Therapeutics Announces Initiation of Phase lll Clinical Trial of DCCR in Prader-Willi Syndrome; 16/05/2018 – SOLENO THERAPEUTICS SAYS QTRLY SHR LOSS FROM CONT OPS $0.17 – SEC FILING; 14/05/2018 – SOLENO THERAPEUTICS INC – TRIAL IS ANTICIPATED TO TAKE APPROXIMATELY 9-12 MONTHS TO COMPLETE

EQUITABLE GROUP INC ORDINARY SHARES CAN (OTCMKTS:EQGPF) had an increase of 1.96% in short interest. EQGPF’s SI was 1.13 million shares in March as released by FINRA. Its up 1.96% from 1.11 million shares previously. With 600 avg volume, 1890 days are for EQUITABLE GROUP INC ORDINARY SHARES CAN (OTCMKTS:EQGPF)’s short sellers to cover EQGPF’s short positions. It closed at $51.03 lastly. It is down 0.00% since March 15, 2018 and is . It has underperformed by 4.37% the S&P500.

Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company has market cap of $42.87 million. The company's lead candidate, diazoxide choline controlled-release , a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It currently has negative earnings. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces.

More notable recent Soleno Therapeutics, Inc. (NASDAQ:SLNO) news were published by: Globenewswire.com which released: “Soleno Therapeutics to Participate in Two Upcoming Investor Conferences – GlobeNewswire” on March 11, 2019, also Streetinsider.com with their article: “Soleno Therapeutics (SLNO) Reports Positive Outcome from Planned DSMB Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome – StreetInsider.com” published on March 14, 2019, Seekingalpha.com published: “Atossa Genetics leads healthcare gainers; Seelos Therapeutics and Presbia among losers – Seeking Alpha” on March 14, 2019. More interesting news about Soleno Therapeutics, Inc. (NASDAQ:SLNO) were released by: Seekingalpha.com and their article: “An In-Depth Look At Soleno Therapeutics – Seeking Alpha” published on February 13, 2019 as well as Benzinga.com‘s news article titled: “Daily Biotech Pulse: KaryoPharm’s Selinexor Review Delayed, FDA Accepts Adamas Opioid Overdose Drug NDA – Benzinga” with publication date: March 15, 2019.

Equitable Group Inc., through its subsidiary, Equitable Bank, provides various financial services to retail and commercial clients in Canada. The company has market cap of $851.78 million. The Company’s deposit products include guaranteed investment certificates, high interest savings accounts, and institutional deposit notes. It has a 7.01 P/E ratio. The firm also provides single family lending products, such as mortgages for owner occupied and investment properties comprising detached and semi-detached houses, townhouses, and condos; and commercial lending products that include mortgages on commercial properties comprising mixed-use, multi-unit residential, shopping plaza, professional office, and industrial properties.

More notable recent Equitable Group Inc. (OTCMKTS:EQGPF) news were published by: Seekingalpha.com which released: “Equitable Group declares $0.30 dividend – Seeking Alpha” on February 28, 2019, also Seekingalpha.com with their article: “Hidden Gems: Equitable Group Inc. – Seeking Alpha” published on January 16, 2019, Seekingalpha.com published: “Equitable Group: The Next Home Capital? – Seeking Alpha” on May 01, 2017. More interesting news about Equitable Group Inc. (OTCMKTS:EQGPF) were released by: Seekingalpha.com and their article: “Buffett’s Canadian Invasion: Home Capital Group – Seeking Alpha” published on July 22, 2017 as well as Seekingalpha.com‘s news article titled: “Home Capital Group Is A Good Buy In 2018 – Seeking Alpha” with publication date: June 19, 2018.